These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 25801006

  • 1. Treatment with angiotensin-(1-9) alleviates the cardiomyopathy in streptozotocin-induced diabetic rats.
    Zheng H, Pu SY, Fan XF, Li XS, Zhang Y, Yuan J, Zhang YF, Yang JL.
    Biochem Pharmacol; 2015 May 01; 95(1):38-45. PubMed ID: 25801006
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.
    Hao PP, Yang JM, Zhang MX, Zhang K, Chen YG, Zhang C, Zhang Y.
    Am J Physiol Heart Circ Physiol; 2015 May 01; 308(9):H1007-19. PubMed ID: 25724492
    [Abstract] [Full Text] [Related]

  • 3. Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury.
    Shao Y, He M, Zhou L, Yao T, Huang Y, Lu LM.
    Acta Pharmacol Sin; 2008 Jul 01; 29(7):829-37. PubMed ID: 18565281
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-(1-7) administration attenuates Alzheimer's disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation.
    Chen JL, Zhang DL, Sun Y, Zhao YX, Zhao KX, Pu D, Xiao Q.
    Neuroscience; 2017 Mar 27; 346():267-277. PubMed ID: 28147245
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis.
    Ocaranza MP, Moya J, Barrientos V, Alzamora R, Hevia D, Morales C, Pinto M, Escudero N, García L, Novoa U, Ayala P, Díaz-Araya G, Godoy I, Chiong M, Lavandero S, Jalil JE, Michea L.
    J Hypertens; 2014 Apr 27; 32(4):771-83. PubMed ID: 24463937
    [Abstract] [Full Text] [Related]

  • 6. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
    Sun X, Chen RC, Yang ZH, Sun GB, Wang M, Ma XJ, Yang LJ, Sun XB.
    Food Chem Toxicol; 2014 Jan 27; 63():221-32. PubMed ID: 24269735
    [Abstract] [Full Text] [Related]

  • 7. Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat.
    Shimoni Y, Hunt D, Chuang M, Chen KY, Kargacin G, Severson DL.
    J Physiol; 2005 Aug 15; 567(Pt 1):177-90. PubMed ID: 15946965
    [Abstract] [Full Text] [Related]

  • 8. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
    Chan P, Liu IM, Tzeng TF, Yang TL, Cheng JT.
    Diabetes Obes Metab; 2007 Jan 15; 9(1):39-49. PubMed ID: 17199717
    [Abstract] [Full Text] [Related]

  • 9. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
    Zhou G, Li X, Hein DW, Xiang X, Marshall JP, Prabhu SD, Cai L.
    J Am Coll Cardiol; 2008 Aug 19; 52(8):655-66. PubMed ID: 18702970
    [Abstract] [Full Text] [Related]

  • 10. Combination of angiotensin-(1-7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy.
    Hao P, Yang J, Liu Y, Zhang M, Zhang K, Gao F, Chen Y, Zhang C, Zhang Y.
    Sci Rep; 2015 Mar 05; 5():8794. PubMed ID: 25740572
    [Abstract] [Full Text] [Related]

  • 11. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
    Soetikno V, Sari FR, Sukumaran V, Lakshmanan AP, Mito S, Harima M, Thandavarayan RA, Suzuki K, Nagata M, Takagi R, Watanabe K.
    Eur J Pharm Sci; 2012 Oct 09; 47(3):604-14. PubMed ID: 22564708
    [Abstract] [Full Text] [Related]

  • 12. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.
    Singh R, Singh AK, Leehey DJ.
    Am J Physiol Renal Physiol; 2005 Jun 09; 288(6):F1183-90. PubMed ID: 15701818
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes.
    Fiordaliso F, Cuccovillo I, Bianchi R, Bai A, Doni M, Salio M, De Angelis N, Ghezzi P, Latini R, Masson S.
    Life Sci; 2006 Jun 06; 79(2):121-9. PubMed ID: 16445948
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Beneficial effects of angiotensin (1-7) in diabetic rats with cardiomyopathy.
    Singh K, Singh T, Sharma PL.
    Ther Adv Cardiovasc Dis; 2011 Jun 06; 5(3):159-67. PubMed ID: 21558085
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of angiotensin receptor blocker on oxidative stress and cardio-renal function in streptozotocin-induced diabetic rats.
    Arozal W, Watanabe K, Veeraveedu PT, Ma M, Thandavarayan RA, Suzuki K, Tachikawa H, Kodama M, Aizawa Y.
    Biol Pharm Bull; 2009 Aug 06; 32(8):1411-6. PubMed ID: 19652382
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage.
    Yang J, Tan Y, Zhao F, Ma Z, Wang Y, Zheng S, Epstein PN, Yu J, Yin X, Zheng Y, Li X, Miao L, Cai L.
    Am J Physiol Endocrinol Metab; 2011 Jul 06; 301(1):E132-44. PubMed ID: 21487074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.